Provided by Tiger Trade Technology Pte. Ltd.

Tredegar

7.14
-0.2600-3.51%
Volume:65.35K
Turnover:472.54K
Market Cap:249.26M
PE:7.46
High:7.48
Open:7.48
Low:7.13
Close:7.40
52wk High:10.53
52wk Low:6.25
Shares:34.91M
Float Shares:28.20M
Volume Ratio:0.67
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9572
EPS(LYR):0.9604
ROE:15.47%
ROA:6.50%
PB:1.09
PE(LYR):7.43

Loading ...

TG Therapeutics price target raised to $70 from $60 at H.C. Wainwright

TIPRANKS
·
May 07

Analysts’ Opinions Are Mixed on These Healthcare Stocks: TG Therapeutics (TGTX) and Insulet (PODD)

TIPRANKS
·
May 07

TG Therapeutics Up Over 14%, on Pace for Largest Percent Increase Since August 2024 -- Data Talk

Dow Jones
·
May 07

TG Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 07

TG Therapeutics Q1 Adj. EPS $0.18 Misses $0.30 Estimate, Sales $204.918M Beat $196.814M Estimate

Benzinga Earnings
·
May 06

Earnings Flash (TGTX) TG Therapeutics Posts Q1 EPS $0.12, vs. FactSet Est of $0.28

MT Newswires Live
·
May 06

TG-17 Reshapes Capital Structure with New Financing Terms

TIPRANKS
·
May 04

Amarin Reports 2026 First Quarter Financial Results

GlobeNewswire
·
Apr 29

TG Metals boosts Van Uden gold resource and advances lithium processing technology

TIPRANKS
·
Apr 28

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting

GlobeNewswire
·
Apr 22

TG Metals details advanced WA gold and lithium projects and data caveats

TIPRANKS
·
Apr 20

TG Metals to Release 5.7 Million Shares From Escrow in April 2026

TIPRANKS
·
Apr 17

Goldman Sachs Reaffirms Their Hold Rating on TG Therapeutics (TGTX)

TIPRANKS
·
Apr 16

American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction

GlobeNewswire
·
Apr 08

Analysts Conflicted on These Healthcare Names: TG Therapeutics (TGTX), Insmed (INSM) and Solventum Corporation (SOLV)

TIPRANKS
·
Apr 08

Tredegar FY25 net income from ongoing operations rises to $25.7 million; net sales climbs to $698.7 million

Reuters
·
Apr 08

TG Tech Announces 2025 Annual Report Highlights and Dividend Plan

TIPRANKS
·
Mar 31

TG-17 Amends Equity Line Agreement to Refine Issuance

TIPRANKS
·
Mar 30

Tredegar announces virtual annual shareholder meeting; FY2025 audit fees drop to $2.97 million

Reuters
·
Mar 26

TG Therapeutics Credit Deal And Valuation Gap Catch Investor Attention

Simply Wall St.
·
Mar 22